Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$79.65
-0.7%
$84.01
$56.72
▼
$92.59
$29.73B1.454.96 million shs1.07 million shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$14.92
-6.8%
$26.77
$13.74
▼
$40.99
$3.50B2.5322.06 million shs7.50 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-2.82%-1.47%-6.47%-13.16%+34.25%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.42%-18.92%-45.05%-52.42%-55.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$79.65
-0.7%
$84.01
$56.72
▼
$92.59
$29.73B1.454.96 million shs1.07 million shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$14.92
-6.8%
$26.77
$13.74
▼
$40.99
$3.50B2.5322.06 million shs7.50 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-2.82%-1.47%-6.47%-13.16%+34.25%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.42%-18.92%-45.05%-52.42%-55.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
3.00
Buy$95.5019.91% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$31.53111.29% Upside

Current Analyst Ratings Breakdown

Latest DXCM and HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetHold$31.00 ➝ $24.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetEqual Weight$28.00 ➝ $25.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetBuy$42.00 ➝ $32.00
11/4/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Reiterated RatingSell (D)
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingStrong-Buy$94.00 ➝ $97.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetBuy$90.00 ➝ $97.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetBuy$102.00 ➝ $107.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetNeutral$82.00 ➝ $85.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetOverweight$115.00 ➝ $120.00
10/26/2026
DexCom, Inc. stock logo
DXCM
DexCom
Lower Price TargetOutperform$94.00 ➝ $87.00
10/13/2026
DexCom, Inc. stock logo
DXCM
DexCom
Set Price Target$95.00 ➝ $100.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.37$2.67 per share29.80$6.80 per share11.71
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B1.49$0.73 per share20.37$1.52 per share9.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5531.2625.861.3619.42%37.77%15.98%N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.83N/AN/AN/A-6.65%-9.62%-1.38%N/A

Latest DXCM and HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0563$0.0280-$0.0283-$0.14$893.13 million$890.37 million
10/29/2026Q3 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6750$0.73+$0.0550$0.72$1.33 billion$1.34 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.49
1.74
1.40
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
3.85
0.92
0.84

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000372.95 million371.91 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442234.41 million206.85 millionOptionable

Recent News About These Companies

Hims & Hers Announces Launch of Peptides+ Specialty
Could Hims & Hers Stock Fall 63% Again?
HLTH 2026: Noom, Hims & Hers expand into booming peptide market
Hims & Hers launches Peptides+ as federal restrictions ease
Hims Is Getting into Peptides
Hims & Hers Health (NYSE:HIMS) CFO Sells 3,518 Shares of Stock
Hims & Hers Stock Fell 32% As Profit Slipped

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DexCom stock logo

DexCom NASDAQ:DXCM

$79.65 -0.54 (-0.68%)
As of 12:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$14.92 -1.10 (-6.84%)
As of 12:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.